Protalix Biotherapeutics Inc (NYSE American:PLX)
| 4.20 BATS BZX Real-Time Price As of 3:13pm ET |  -0.44 / -9.48%Today’s Change | 2.04 Today|||52-Week Range 7.02 | +15.70% Year-to-Date |
Latest PLX News | Press Releases
No recent news for Protalix Biotherapeutics Inc.
Today’s Trading
| Previous close | 4.64 |
| Today’s open | 4.63 |
| Day’s range | 3.93 - 4.64 |
| Volume | 1,059,048 |
| Average volume (3 months) | 529,662 |
| Market cap | $216.8M |
Data as of 3:13pm ET, 03/04/2021
Growth & Valuation
| Earnings growth (last year) | +31.50% |
| Earnings growth (this year) | +72.76% |
| Earnings growth (next 5 years) | +25.00% |
| Revenue growth (last year) | +59.73% |
| P/E ratio | NM |
| Price/Sales | 0.89 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| IDRAIdera Pharmaceutical... | -0.51 | -10.58% |
| DRIODarioHealth Corp | -1.69 | -6.60% |
| MDNAMedicenna Therapeuti... | -0.23 | -5.85% |
| NEPTNeptune Wellness Sol... | -0.13 | -8.28% |
Data as of 3:13pm ET, 03/04/2021
Financials
| Next reporting date | March 18, 2021 |
| EPS forecast (this quarter) | -$0.09 |
| Annual revenue (last year) | $54.7M |
| Annual profit (last year) | -$18.3M |
| Net profit margin | -33.42% |
Profile
Sector Health Services |
Industry Services to the Health Industry |
No executives to display |
Corporate headquarters Karmiel, Hazafon |
Forecasts
